Rampart Bioscience

About:

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Website: https://rampartbio.com/

Top Investors: OrbiMed, RA Capital Management, Forbion Capital Partners, HealthCap

Description:

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from a variety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Total Funding Amount:

$85M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2019-01-01

Founders:

Louis Breton

Number of Employees:

1-10

Last Funding Date:

2023-10-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai